Race and prostate cancer: genomic landscape

被引：18
|
作者：
Arenas-Gallo, Camilo [1 ]
Owiredu, Jude [2 ]
Weinstein, Ilon [1 ]
Lewicki, Patrick [2 ]
Basourakos, Spyridon P. [2 ]
Vince, Randy, Jr. [3 ]
Al Awamlh, Bashir Al Hussein [2 ,4 ]
Schumacher, Fredrick R. [5 ,6 ]
Spratt, Daniel E. [7 ]
Barbieri, Christopher E. [2 ]
Shoag, Jonathan E. [1 ,2 ,6 ]
机构：
[1] Case Western Reserve Univ, Sch Med, Dept Urol, Univ Hosp Cleveland Med Ctr, Cleveland, OH 44106 USA
[2] Weill Cornell Med, Dept Urol, NewYork Presbyterian Hosp, New York, NY 10021 USA
[3] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA
[4] Vanderbilt Univ, Dept Urol, Med Ctr, Nashville, TN USA
[5] Case Western Reserve Univ, Sch Med, Dept Populat & Quantitat Hlth Sci, Cleveland, OH USA
[6] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA
[7] Case Western Reserve Univ, Sch Med, Dept Radiat Oncol, Univ Hosp Seidman Canc Ctr, Cleveland, OH USA
来源：
NATURE REVIEWS UROLOGY | 2022年 / 19卷 / 09期
关键词：
DIFFERENTIALLY METHYLATED GENES; AFRICAN-AMERICAN; HIGH-GRADE; HEALTH DISPARITIES; GERMLINE MUTATIONS; INTRAEPITHELIAL NEOPLASIA; DNA HYPOMETHYLATION; PROGNOSTIC VALUE; ERG ONCOPROTEIN; SPOP MUTATIONS;
D O I：
10.1038/s41585-022-00622-0
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
In this Review, the authors discuss racial differences in the prevalence of genetic mutations in the main molecular drivers of prostate cancer and provide input regarding the role of genomics in racial disparities observed in prostate cancer outcomes. In the past 20 years, new insights into the genomic pathogenesis of prostate cancer have been provided. Large-scale integrative genomics approaches enabled researchers to characterize the genetic and epigenetic landscape of prostate cancer and to define different molecular subclasses based on the combination of genetic alterations, gene expression patterns and methylation profiles. Several molecular drivers of prostate cancer have been identified, some of which are different in men of different races. However, the extent to which genomics can explain racial disparities in prostate cancer outcomes is unclear. Future collaborative genomic studies overcoming the underrepresentation of non-white patients and other minority populations are essential.
引用
收藏
页码：547 / 561
页数：15
相关论文
共 50 条
  • [21] Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations
    Bottcher, Rene
    Kweldam, Charlotte F.
    Livingstone, Julie
    Lalonde, Emilie
    Yamaguchi, Takafumi N.
    Huang, Vincent
    Yousif, Fouad
    Fraser, Michael
    Bristow, Robert G.
    van der Kwast, Theodorus
    Boutros, Paul C.
    Jenster, Guido
    van Leenders, Geert J. L. H.
    BMC CANCER, 2018, 18
  • [22] The genomic landscape of phaeochromocytoma
    Flynn, Aidan
    Benn, Diana
    Clifton-Bligh, Roderick
    Robinson, Bruce
    Trainer, Alison H.
    James, Paul
    Hogg, Annette
    Waldeck, Kelly
    George, Joshy
    Li, Jason
    Fox, Stephen B.
    Gill, Anthony J.
    McArthur, Grant
    Hicks, Rodney J.
    Tothill, Richard W.
    JOURNAL OF PATHOLOGY, 2015, 236 (01) : 78 - 89
  • [23] Trends in the Incidence of Fatal Prostate Cancer in the United States by Race
    Kelly, Scott P.
    Rosenberg, Philip S.
    Anderson, William F.
    Andreotti, Gabriella
    Younes, Naji
    Cleary, Sean D.
    Cook, Michael B.
    EUROPEAN UROLOGY, 2017, 71 (02) : 195 - 201
  • [24] Considering race and the potential for ERG expression as a biomarker for prostate cancer
    Powell, Isaac J.
    Dyson, Gregory
    Chinni, Sreenivasa R.
    Bollig-Fischer, Aliccia
    PERSONALIZED MEDICINE, 2014, 11 (04) : 409 - 412
  • [25] Genomic tests to guide prostate cancer management following diagnosis
    Colicchia, Michele
    Morlacco, Alessandro
    Cheville, John C.
    Karnes, R. Jeffrey
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2017, 17 (04) : 367 - 377
  • [26] Genomic classifiers for treatment selection in newly diagnosed prostate cancer
    Fine, Noam David
    LaPolla, Fred
    Epstein, Matthew
    Loeb, Stacy
    Dani, Hasan
    BJU INTERNATIONAL, 2019, 124 (04) : 578 - 586
  • [27] Racial disparity in prostate cancer: an outlook in genetic and molecular landscape
    Kaushal, Jyoti B.
    Raut, Pratima
    Muniyan, Sakthivel
    Siddiqui, Jawed A.
    Alsafwani, Zahraa W.
    Seshacharyulu, Parthasarathy
    Nair, Sujit S.
    Tewari, Ashutosh K.
    Batra, Surinder K.
    CANCER AND METASTASIS REVIEWS, 2024, 43 (04) : 1233 - 1255
  • [28] The impact of African American race on prostate cancer detection on repeat prostate biopsy in a veteran population
    William A. Sterling
    Joseph Weiner
    David Schreiber
    Komal Mehta
    Jeffrey P. Weiss
    International Urology and Nephrology, 2016, 48 : 2015 - 2021
  • [29] Bridging Health Disparities: a Genomics and Transcriptomics Analysis by Race in Prostate Cancer
    Lee, Kristi Y.
    Beatson, Erica L.
    Steinberg, Seth M.
    Chau, Cindy H.
    Price, Douglas K.
    Figg, William D.
    JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES, 2024, 11 (01) : 492 - 504
  • [30] Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer
    Vickie L. Shavers
    Martin L. Brown
    Arnold L. Potosky
    Carrie N. Klabunde
    W. W. Davis
    Judd W. Moul
    Angela Fahey
    Journal of General Internal Medicine, 2004, 19 : 146 - 155
12345